Sumatriptan Succinate

CAS 103628-48-4 10 FDA-DMF suppliersSmall Molecule

Overview

Sumatriptan Succinate is a selective serotonin receptor agonist used primarily in the treatment of migraine attacks. It functions by narrowing blood vessels in the brain, stopping pain signals, and affecting other substances that can trigger migraine symptoms.

API suppliers (21)

Suppliers of Sumatriptan Succinate backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

  • Natco PharmaIndia1 active DMF
  • QUIMICA SINTETICA SASpain1 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • MOEHS IBERICA SLSpain1 active DMF
  • MOEHS IBERICA SLSpain1 active DMF
  • Natco PharmaIndia1 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • QUIMICA SINTETICA SASpain1 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • Natco PharmaIndia1 active DMF
  • QUIMICA SINTETICA SASpain1 active DMF
  • MOEHS IBERICA SLSpain1 active DMF
  • QUIMICA SINTETICA SASpain1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • Dr. Reddy's Laboratories Ltd.India1 active DMF
  • Natco PharmaIndia1 active DMF
  • MOEHS IBERICA SLSpain1 active DMF
  • ORBION PHARMACEUTICALS PRIVATE LTDIndia1 active DMF
  • ASYMCHEM LIFE SCIENCE TIANJIN CO LTDChina
  • JBC Pharmaceuticals Ltd.United Kingdom

Therapeutic areas

MigraineHeadache DisordersNeurology

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.